DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma

被引:0
|
作者
Thomas Fleischer
Hege Edvardsen
Jovana Jovanovic
Nizar Touleimat
Anne-Lise Børresen-Dale
Jörg Tost
Vessela N Kristensen
机构
[1] Oslo University Hospital Radiumhospitalet,Department of Genetics, Institute for Cancer Research
[2] University of Oslo,The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine
[3] University of Oslo,Institute for Clinical Epidemiology and Molecular Biology (EpiGen), Faculty of Medicine
[4] Centre National de Génotypage,Laboratory for Epigenetics
[5] CEA - Institut de Génomigue,undefined
关键词
Breast Cancer; Invasive Carcinoma; Mammographic Density; Gene Body; Inhibit Gene Expression;
D O I
10.1186/1756-8935-6-S1-P18
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Gene expression differences between ductal carcinoma in situ with and without progression to invasive breast cancer
    Doebar, S. C.
    Sieuwerts, A. M.
    de Weerd, V.
    Martens, J. W. M.
    van Deurzen, C. H. M.
    CANCER RESEARCH, 2017, 77
  • [2] Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer
    Doebar, Shusma C.
    Sieuwerts, Anieta M.
    de Weerd, Vanja
    Stoop, Hans
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (07): : 1648 - 1655
  • [3] Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
    Cowell, Catherine F.
    Weigelt, Britta
    Sakr, Rita A.
    Ng, Charlotte K. Y.
    Hicks, James
    King, Tari A.
    Reis-Filho, Jorge S.
    MOLECULAR ONCOLOGY, 2013, 7 (05) : 859 - 869
  • [4] Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
    Song, Guiqin
    He, Lang
    Yang, Xiaolin
    Yang, Yan
    Cai, Xiaoming
    Liu, Kang
    Feng, Gang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
  • [5] Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
    Fleischer, Thomas
    Frigessi, Arnoldo
    Johnson, Kevin C.
    Edvardsen, Hege
    Touleimat, Nizar
    Klajic, Jovana
    Riis, Margit L. H.
    Haakensen, Vilde D.
    Warnberg, Fredrik
    Naume, Bjorn
    Helland, Aslaug
    Borresen-Dale, Anne-Lise
    Tost, Jorg
    Christensen, Brock C.
    Kristensen, Vessela N.
    GENOME BIOLOGY, 2014, 15 (08):
  • [6] Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
    Erik S. Knudsen
    Adam Ertel
    Elai Davicioni
    Jessica Kline
    Gordon F. Schwartz
    Agnieszka K. Witkiewicz
    Breast Cancer Research and Treatment, 2012, 133 : 1009 - 1024
  • [7] Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
    Witkiewicz, Agnieszka
    Ertel, Adam
    Knudsen, Erik S.
    CANCER RESEARCH, 2012, 72
  • [8] Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
    Knudsen, Erik S.
    Ertel, Adam
    Davicioni, Elai
    Kline, Jessica
    Schwartz, Gordon F.
    Witkiewicz, Agnieszka K.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1009 - 1024
  • [9] DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
    Kevin C. Johnson
    Devin C. Koestler
    Thomas Fleischer
    Panpan Chen
    Erik G. Jenson
    Jonathan D. Marotti
    Tracy Onega
    Vessela N. Kristensen
    Brock C. Christensen
    Clinical Epigenetics, 2015, 7
  • [10] DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
    Johnson, Kevin C.
    Koestler, Devin C.
    Fleischer, Thomas
    Chen, Panpan
    Jenson, Erik G.
    Marotti, Jonathan D.
    Onega, Tracy
    Kristensen, Vessela N.
    Christensen, Brock C.
    CLINICAL EPIGENETICS, 2015, 7